J.T.SMITH & SON PHARMA LIMITED Financials
- Company number
- 06157479CopyCopy
- Registered office
- 6th Floor, Amp House, Dingwall Road, Croydon CR0 2LX
- Incorporated
- 13/03/2007
Company snapshot
- Status
- Active
- Employees
- 5 (2025)
- Latest financial data
- 2025
- Accounts type
- Unaudited abridged
Financial highlights
Latest reported figures. Okredo holds filed data for 2021–2025.
Net Assets
9.42%vs 20242024: £462.47K
Total Assets
2.20%vs 20242024: £1.38M
Cash in Bank
7.94%vs 20242024: £1.09M
Total Liabilities
-1.46%vs 20242024: £915.10K
Employees
0vs 20242024: 5
In 2025, J.T.SMITH & SON PHARMA LIMITED reported net assets of £506.03K. The same filing shows total assets of £1.41M, cash in bank of £1.17M and total liabilities of £901.78K. Reported headcount was 5 in 2025. Cash in Bank rose from £1.09M in 2024 to £1.17M in 2025 (7.94%). Okredo holds filed figures for 2021–2025; the table below lists every reported indicator by year. See every reported indicator by year.
Financial performance
Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.
Net Assets
9.42%from £462.47K in 2024Year-on-year change
Net Assets as filed for 2021–2025. Every figure in this chart is also in the financial history table.
3-year financial trend (2023–2025)
How the figures J.T.SMITH & SON PHARMA LIMITED filed moved across the three reported years 2023, 2024 and 2025 — measured end to end rather than year on year.
Net Assets
+28.6%vs 2023+13.4% a year compound (CAGR)
Cash in Bank
+17.2%vs 2023+8.2% a year compound (CAGR)
Total Assets
+8.3%vs 2023+4.1% a year compound (CAGR)
Total Liabilities
-0.4%vs 2023-0.2% a year compound (CAGR)
Employees
0%vs 2023Biggest increase
Net Assets+28.6%
£393.42K in 2023 to £506.03K in 2025
Biggest decrease
Total Liabilities-0.4%
£905.52K in 2023 to £901.78K in 2025
J.T.SMITH & SON PHARMA LIMITED's filings pull in both directions between 2023 and 2025. The steepest rise came in net assets, pointing to a strengthening balance sheet, set against a fall in total liabilities, pointing to lighter outstanding obligations. See the full year-by-year figures.
Ratios from the filed figures
Calculated from J.T.SMITH & SON PHARMA LIMITED's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.
- Net assets to total assets
- 35.90%2025
- Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.
- Liabilities to total assets
- 63.98%2025
- Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.
- Cash to liabilities
- 129.95%2025
- Reported cash in bank divided by total liabilities for the same year. Shows what share of outstanding obligations the reported cash balance would cover.
- Cash to total assets
- 83.14%2025
- Reported cash in bank divided by reported total assets, for the latest year both were filed.
Financial history
Every indicator Okredo tracks, year by year.
Reported financial indicators for J.T.SMITH & SON PHARMA LIMITED by year. Amounts are as filed; a dash means the figure was not reported for that year.
| Indicator | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Assets£ | 184.41K | 300.33K | 393.42K | 462.47K | 506.03K |
| Total Assets£ | 1.09M | 1.17M | 1.30M | 1.38M | 1.41M |
| Cash in Bank£ | 690.66K | 881.70K | 1.00M | 1.09M | 1.17M |
| Total Liabilities£ | 900.55K | 869.40K | 905.52K | 915.10K | 901.78K |
| Employees | 7 | 6 | 5 | 5 | 5 |
J.T.SMITH & SON PHARMA LIMITED financials: frequently asked questions
Answered from this company's own filed figures.
Yes. Okredo holds filed figures for J.T.SMITH & SON PHARMA LIMITED covering 2021–2025, across 5 reported indicators. The most recent reported year is 2025.
J.T.SMITH & SON PHARMA LIMITED reported net assets of £506.03K for 2025. That compares with £462.47K in 2024, a change of 9.42%.
J.T.SMITH & SON PHARMA LIMITED reported total assets of £1.41M for 2025. That compares with £1.38M in 2024, a change of 2.20%.
J.T.SMITH & SON PHARMA LIMITED reported cash in bank of £1.17M for 2025. That compares with £1.09M in 2024, a change of 7.94%.
J.T.SMITH & SON PHARMA LIMITED reported 5 employees in 2025, compared with 5 in 2024.
Between 2023 and 2025, J.T.SMITH & SON PHARMA LIMITED's net assets rose by 28.6%, cash in bank rose by 17.2%, total assets rose by 8.3% and total liabilities fell by 0.4%. Net assets compounded at 13.4% a year across the two years to 2025, from £393.42K to £506.03K. Reported headcount went from 5 in 2023 to 5 in 2025.
Okredo holds reported figures for the years 2021, 2022, 2023, 2024, 2025. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.